Tokyo connection

Remiges Ventures is entering the company creation business, with a strategic investment from the University of Tokyo that will provide a pipeline of potential spinouts.

The final close of the firm’s Remiges BioPharma Fund L.P. came on Feb. 14 with a $10 million investment from UTokyo Innovation Platform, University of Tokyo's strategic investment arm...